Heavy air pollution tied to ‘worsening lung damage’

Vaping companies sue

NEW YORK, Aug 15, (Agencies): The more exposure people have to air pollution, especially ozone, the more lung damage they develop over time, a US study suggests.

Researchers already knew that heavy air pollution makes lung disease worse in people who already have lung disease. The new study shows that even among people without lung disease, longterm exposure to air pollution even in relatively ‘clean’ areas can lead to signs of chronic lung disease, said Dr Joel Kaufman, a co-author of the study and an environmental health researcher at the University of Washington in Seattle.

The current study focused on four major pollutants – ozone, an unstable form of oxygen produced when traffic and industrial fumes react with sunlight; nitrogen oxide, a byproduct of fossil fuel combustion that contributes to smog; black carbon, or soot, from coal-powered factories and traffic; and so-called PM 2.5, a mixture of solid particles and liquid droplets smaller than 2.5 micrometers in diameter that can include dust, dirt, soot and smoke.

Researchers assessed levels of these pollutants near the homes of 7,071 people in six US cities: Baltimore; Chicago; Los Angeles; St Paul, Minnesota; New York, and Winston-Salem, North Carolina. Each participant got CT scans to look for the proportion of cells in the lung that are damaged – described as the percentage of emphysema. They also underwent lung function tests known as spirometry at the start of the study and again around 10 years later.

Exhalation

About 46% of the study group were lifelong nonsmokers, and 22% of participants had some airflow obstruction at the beginning of the study period. Over 10 years, the average decline in lung function for the entire group was a little over 300 milliliters of volume on inhalation and exhalation tests.

People exposed to higher levels of each of the four pollutants at the start of the study were more likely to develop emphysema damage by the end, researchers report in JAMA.

Levels of most of the pollutants declined during the study, but concentrations of ozone rose. Each 3 parts per billion (ppb) of ozone in the air was associated with a lung function decline of 18 ml on a test of forced exhalation, and 40 ml on an inhalation test.

Over the 10-year period, each 3 ppb in average daily exposure to ozone was linked to lung damage equivalent to smoking a pack of cigarettes a day for 29 years or to an additional three years of aging, researchers found.

Ever-smokers and people with lung damage at the start of the study experienced the greatest increases in percentage emphysema and declines in lung function.

The results suggest that air pollution exposure may help explain why so many people without any history of smoking still develop chronic emphysema, the study team concludes.

One limitation of the study is that researchers only examined air pollution around people’s home addresses, and it’s unclear how much time people spent at work or other places away from home or how much pollution levels might differ at these other locations.

“People don’t spend all their time sitting on their front steps, so while we have a very good idea about their air pollution exposures, the exposures are a bit different indoors and when they travel to other places,” Kaufman said.

Even so, the results underscore how important it is for people with chronic lung diseases to take precautions to limit exposure to air pollution, Kaufman advised.

“Staying indoors on high air pollution days and having a good air filter at home can be helpful in highly polluted environments,” Kaufman said.

The results also highlight the importance of public health efforts to curb pollution.

“Great progress has been made in reducing air pollution concentrations due to health-based air quality protections and these need to continue to be strengthened,” Kaufman said. “Ozone concentrations in particular still need attention and reducing use of fossil fuels and slowing climate change will help reduce these exposures too.”

Also:

WASHINGTON: A vaping industry group sued the US government on Wednesday to delay an upcoming review of thousands of e-cigarettes on the market.

The legal challenge by the Vapor Technology Association is the latest hurdle in the Food and Drug Administration’s yearslong effort to regulate the multibilliondollar vaping industry, which includes makers and retailers of e-cigarette devices and flavored solutions.

The vaping group argued that the latest deadline of next May to submit products for review could wipe out many of the smaller companies. The lawsuit was filed in US District Court in Kentucky.

E-cigarettes first appeared in the US more than a decade ago and have grown in popularity despite little research on their long-term effects, including whether they can help smokers quit cigarettes.

In recent years, health authorities have warned of an epidemic of vaping by underage teenagers, particularly the leading brand Juul, known for its high nicotine content and easy-to-conceal device, which resembles a flash drive.

Nicotine is what makes both cigarettes and e-cigarettes addictive, and health experts say the chemical is harmful to developing brains.

San Francisco-based Juul is among 800 member companies of the vaping association.

The 2009 law that gave the FDA power over the traditional tobacco products did not mention e-cigarettes. And it wasn’t until 2016 that the agency expanded its own regulations to include the devices. But since then FDA regulators have repeatedly pushed back the timeline, at one point until 2022, to begin review the legions of vaping products that have come to market.